Severe congenital neutropenia terminating in acute myeloid disease progression associated with mutations in the granulocyte-colony stimulating factor receptor gene

Leukemia Research

Volumn 20, Issue 8, 1996, Pages 629-631

  Touw, Ivo P ^a,b   Dong, Fan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

G CSF R defects; Progression to acute myeloblastic leukemia; Severe congenital neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR RECEPTOR; MUTANT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; CARBOXY TERMINAL SEQUENCE; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; NEUTROPENIA; NONSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR GENE; SHORT SURVEY;

EID: 0030221525     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(96)00017-3     Document Type: Review

References (20)

1. 1. Kostmann R. (1956) Infantile genetic agranulocytosis. Acta Paediatr. Scand. 45, (Suppl. 105), 1.
2. 2. Dale D. C., Davis M. & Vincent M. E. (1994) Use of filgrastim (r-metHuG-CSF) in severe chronic neutropenia. In Filgrastin in Clinical Practice (Morstyn G. & Dexter T. M., Eds), pp. 83-101. Marcel Dekker, New York.
3. 3. Mempel K., Pietsch T., Menzel T., Zeidler C. & Welte K. (1991) Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 77, 1919.
4. 4. Gillio A. P. & Gabrilove J. L. (1993) Cytokine treatment of inherited bone marrow failure syndromes. Blood 81, 1669.
5. 5. Bonilla M. A., Dale D., Zeidler C., Last L., Reiter A., Ruggeiro M., Davis M., Koci B., Hammond W., Gillio A. & Welte K. (1994) Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br. J. Haematol. 88, 723.
6. 6. Welte K., Zeidler C., Reiter A., Müller W., Odenwald E., Souza L. & Riehm H. (1990) Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75, 1056.
7. 7. Gilman P. A., Jackson D. P. & Guild H. G. (1970) Congenital agranulocytosis: prolonged survival and terminal acute leukemia. Blood 36, 576.
8. 8. Rosen R. B. & Kang S. J. (1979) Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J. Pediatr. 94, 406.
9. 9. Wong W.-Y., Williams D., Slovak M. L., Charak B., Mazumder A., Snyder D., Powars D. R. & Brynes R. K. (1993) Terminal acute myelogenous leukemia in a patient with congenital agranulocytosis. Am. J. Hematol. 43, 133.
10. 10. Bazan J. F. (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc. natn. Acad. Sci. USA 87, 6934.
11. 11. Pietsch T., Bührer C., Mempel K., Menzel T., Steffens U., Schrader C., Santos F., Zeidler C. & Welte K. (1991) Blood mononuclear cells from patients with severe congenital neutropenia are capable of producing granulocyte colony-stimulating factor. Blood 77, 1234.
12. 12. Dong F., Hoefsloot L. H., Schelen A. M., Breeders L. C. A. M., Meijer Y., Veerman A. J. P., Touw I. P. & Löwenberg B. (1994) Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc. natn. Acad. Sci. USA 91, 4480.
13. 13. Dong F., Van Buitenen C., Pouwels K., Hoefsloot L. H., Löwenberg B. & Touw I. P. (1993) Distinct cytoplasmic regions of the granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol. Cell. Biol. 13, 7774.
14. 14. Fukunaga R., Ishizaka-Ikeda E. & Nagata S. (1993) Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony stimulating factor receptor. Cell 74, 1079.
15. 15. Dong F., Brynes R. K., Tidow N., Welte K., Löwenberg B. & Touw I. P. (1995) Mutations truncating the C-terminal maturation region of the G-CSF receptor in acute myeloid leukemia preceded by severe congenital neutropenia. N. Engl. J. Med. 333, 487.
16. 16. Kalra R., Dale D., Freedman M., Bonilla M. A., Weinblatt M., Ganser A., Bowman P., Abish S., Priest J., Oseas R. S., Olson K., Paderanga D. & Shannon K. (1995) Monosomy and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 86, 4579.
17. 17. Guba S. C., Sartor C. A., Hutchinson R., Boxer L. A. & Emerson S. G. (1994) Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia. Blood 83, 1486.
18. 18. Sandoval C., Parganas E., Wang W. & Ihle J. N. (1995) Lack of alterations in the cytoplasmic domains of the granulocyte colony-stimulating factor receptors in eight cases of severe congenital neutropenia (Letter to the Editor). Blood 85, 852.
19. 19. Rauprich P., Kasper B., Tidow N. & Welte K. (1995) The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia. Blood 86, 4500.
20. 20. Dong F., Van Paassen M., Van Buitenen C., Hoefsloot L. H., Löwenberg B. & Touw I. P. (1995) A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukemia results in the overexpression of a novel G-CSF-R isoform. Blood 85, 902.